Equities

Shandong Buchang Pharmaceuticals Co Ltd

603858:SHH

Shandong Buchang Pharmaceuticals Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)15.17
  • Today's Change0.16 / 1.07%
  • Shares traded4.68m
  • 1 Year change-14.97%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,0462,8481,690
Total Receivables, Net2,0392,0702,372
Total Inventory4,9303,7893,834
Prepaid expenses255257430
Other current assets, total9.952726
Total current assets8,2818,9918,352
Property, plant & equipment, net6,6056,8636,544
Goodwill, net1,4732,0635,133
Intangibles, net2,3262,1882,136
Long term investments1,7281,5141,450
Note receivable - long term--1723
Other long term assets------
Total assets20,89221,95223,986
LIABILITIES
Accounts payable2,3822,3092,433
Accrued expenses262366375
Notes payable/short-term debt5769611,583
Current portion long-term debt/capital leases754323322
Other current liabilities, total2,8823,0012,449
Total current liabilities6,8566,9617,162
Total long term debt2,1092,1531,922
Total debt3,4403,4383,826
Deferred income tax9188106
Minority interest(241)(88)25
Other liabilities, total460475346
Total liabilities9,2759,5899,561
SHAREHOLDERS EQUITY
Common stock1,1061,1061,142
Additional paid-in capital2,4932,4943,392
Retained earnings (accumulated deficit)8,0088,75110,806
Treasury stock - common(1.85)--(934)
Unrealized gain (loss)171723
Other equity, total(5)(4.7)(3.3)
Total equity11,61712,36314,425
Total liabilities & shareholders' equity20,89221,95223,986
Total common shares outstanding1,1061,1061,106
Treasury shares - common primary issue0.11036
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.